USP9X promotes apoptosis in cholangiocarcinoma by modulation expression of KIF1Bβ via deubiquitinating EGLN3

BACKGROUND: Cholangiocarcinoma represents the second most common primary liver malignancy. The incidence rate has constantly increased over the last decades. Cholangiocarcinoma silent nature limits early diagnosis and prevents efficient treatment. METHODS: Immunoblotting and immunohistochemistry wer...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Biomed Sci
Main Authors: Chen, Weiqian, Song, Jingjing, Liu, Siyu, Tang, Bufu, Shen, Lin, Zhu, Jinyu, Fang, Shiji, Wu, Fazong, Zheng, Liyun, Qiu, Rongfang, Chen, Chunmiao, Gao, Yang, Tu, Jianfei, Zhao, Zhongwei, Ji, Jiansong
Formato: Artigo
Idioma:Inglês
Publicado: BioMed Central 2021
Assuntos:
Research
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8191029/
https://ncbi.nlm.nih.gov/pubmed/34112167
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12929-021-00738-2
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares